During the past decade, University of Louisville Kidney Disease Program conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Louisville Kidney Disease Program" #1 collaborator was "Gambro Renal Products, Inc." with 1 trials as a collaborator, "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)" with 1 trials as a collaborator, "National Institutes of Health (NIH)" with 1 trials as a collaborator, "Rockwell Medical Technologies, Inc." with 1 trials as a collaborator and "University of Louisville" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "University of Louisville Kidney Disease Program" are "Chronic Kidney Disease" (1 trials), "Chronic Renal Disease" (1 trials), "End Stage Renal Disease (ESRD)" (1 trials) and "End-Stage Renal Disease" (1 trials). Many other conditions were trialed in "University of Louisville Kidney Disease Program" in a lesser frequency.

Most popular intervention types in "University of Louisville Kidney Disease Program" are "Other" (2 trials), "Device" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "ESA Dose Adjustment per "Smart Anemia Manager" Algorithm" (1 trials), "ESA Dose Adjustment per standard Anemia Management Protocol" (1 trials), "HD-C4 Small" (1 trials), "Optiflux 160NR" (1 trials) and "Optiflux 200NR" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Louisville Kidney Disease Program" are 3 trials for "All" genders.

Currently, there are NaN active trials in "University of Louisville Kidney Disease Program". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in University of Louisville Kidney Disease Program, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in University of Louisville Kidney Disease Program, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".